CEACAM5 and gastric cancer: The positive rates of serum CA125, AFP, and CEA in the gastric cancer group were also significantly higher compared to the benign group (6.98% vs. 1.51%, 4.16% vs. 1.01%, 19.86% vs. 5.98%), with statistically significant difference (P<0.05).